Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $429000.0.

  • Solesence's Cash & Equivalents fell 8533.33% to $429000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $429000.0, marking a year-over-year decrease of 8533.33%. This contributed to the annual value of $1.4 million for FY2024, which is 1817.65% down from last year.
  • Latest data reveals that Solesence reported Cash & Equivalents of $429000.0 as of Q3 2025, which was down 8533.33% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Cash & Equivalents ranged from a high of $4.1 million in Q2 2025 and a low of $429000.0 during Q3 2025
  • In the last 5 years, Solesence's Cash & Equivalents had a median value of $1.4 million in 2024 and averaged $1.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 23272.45% in 2022, then crashed by 8533.33% in 2025.
  • Quarter analysis of 5 years shows Solesence's Cash & Equivalents stood at $657000.0 in 2021, then surged by 232.72% to $2.2 million in 2022, then dropped by 21.23% to $1.7 million in 2023, then dropped by 18.18% to $1.4 million in 2024, then tumbled by 69.55% to $429000.0 in 2025.
  • Its last three reported values are $429000.0 in Q3 2025, $4.1 million for Q2 2025, and $1.8 million during Q1 2025.